Search results
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC News via Yahoo News· 6 days agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
Best Probiotic Supplements for Weight Loss in 2024
Men's Journal· 4 days agoThe 8 Best Probiotic Supplements to Support Weight Loss, According to an M.D. A healthy gut can boost your overall digestive health and make it easier to...
Samsung Union Goes on First-Ever Strike Over Pay Dispute
Bloomberg via Yahoo Finance· 5 hours ago(Bloomberg) -- The largest union at Samsung Electronics Co. went on a strike for the first time in...
Vanessa Ton discusses the barriers and opportunities for EV adoption by dealers in the U.S.
CBT News· 3 days agoAccording to Kelley Blue Book, EV sales in the U.S. market surpassed 1 million units for the first time in 2023, but not everyone is on board just yet. On today’s episode of CBT Now, we’re discussing ...
The Dark Side of Global Sourcing: ‘Who Pays for the Crisis?’
Sourcing Journal via Yahoo News· 21 hours agoMeanwhile, Bestseller, Next, Inditex and H&M have taken significant steps to make wages a clear,...
Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU
Zacks via Yahoo Finance· 19 hours agoHalozyme (HALO) is set to benefit from the new patent grant in the EU, ensuring the protection of...
FLASH FRIDAY: Evaluating Access Fees Proposal - Traders Magazine
Traders Magazine· 7 days agoFLASH FRIDAY is a weekly content series looking at the past, present and future of capital markets...
Ostrom Climate Provides Corporate Update
Morningstar· 2 days agoVANCOUVER, BC / ACCESSWIRE / June 5, 2024 / Ostrom Climate Solutions Inc. ("Ostrom Climate" or the "Company") (TSX-V:COO)(Frankfurt:9EA), a leading carbon project developer and climate solutions ...
Knightscope gets extension to meet Nasdaq compliance By Investing.com
Investing.com· 2 days agoThe company now has until October 4, 2024, to execute a reverse stock split if necessary and...
JD Supra: Better Health Care Newsletter
JD Supra· 16 hours agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big Pharma in recent years has flouted that charitable intent.